-
Share
9,505 Posts.
660
20/07/09
11:35
Share
Hi everyone,
With the latest news that GSK has already booked orders for 128 Million doses we are close to pass the Mcap of this company.
Hi guys,
I have to say looking at the fundamentals $1.60 must be a steal to buy more BTA.
Just have a quick look
BTA has 175 million shares on issue
BTA has about at $1.60 a Mcap of $280 Million
BTA has around $100 Million cash afer this week
GSK has already booked orders for 128 million doses
Royalty is 7%
1 packet Relenza sells for US$20
128 Million gives Biota around A$128 Million
Just remember we have around $100 Million in the bank
after this week
So the future earnings we KNOW off and the cash in the bank are now around $228 Million
Mcap at $1.60 = $280 Million
You get my thouhgts this company is just CHEAP AS CHIPS and has to at least double from here.
I think that BTA should put out an ASX announcement on this latest news from GSK and forward Relenza sales.
If this is not market sensitive Information , then I do not know what is.
Please do your own research as I own shares in this company and have a biast opinion.
Good luck to all
jojo
-